Mucosal Vaccines

Mucosal tissues (e.g. nasal, oral, ocular, rectal, vaginal) cover a large surface of the body. It is critical to develop strategies for neutralizing the infectious agent at these surfaces because infections are initiated at these sites. Mucosal vaccination involves the administration of vaccines at one or more mucosal sites leading to induction of immune responses at that site, or other mucosal sites. Immunization involves the delivery of antigens to the mucosal immune system. The antigen delivery systems may comprise a simple buffer solution with/without adjuvants or an advanced particulate formulation, such as liposomes or nanoparticles. The most commonly evaluated route for mucosal antigen delivery is oral, but other routes have also been explored.

  • Track 1-1 Edible Vaccines
  • Track 2-2 Common Vaccination given by Mucosal Route
  • Track 3-3 Mucosal Vaccines Delivery
  • Track 4-4 Challenges in Mucosal Vaccine Delivery

Related Conference of Vaccines